feed,title,long_url,short_url
Benzinga,Pfizer's 20-Valent Pneumococcal Vaccine Hits Primary Goal In Infant Trial,https://benzinga.com/general/biotech/22/08/28473379/pfizers-20-valent-pneumococcal-vaccine-hits-primary-goal-in-infant-trial,https://bit.ly/3QmSFZc
Benzinga,Aptinyx's Chronic Pain Candidate Fails To Top Placebo In Mid-Stage Study,https://benzinga.com/general/biotech/22/08/28473030/aptinyxs-chronic-pain-candidate-fails-to-top-placebo-in-mid-stage-study,https://bit.ly/3zQAsMD
